Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth-Reference-Cited by-同舟云学术

Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth

Published:2021-06-08 Issue:7 Volume:13 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Wang Yuyi¹,Salvucci Ombretta¹,Ohnuki Hidetaka¹,Tran Andy D²,Ha Taekyu¹,Feng Jing‐Xin¹^ORCID,DiPrima Michael¹,Kwak Hyeongil¹^ORCID,Wang Dunrui¹^ORCID,Yu Yanlin³,Kruhlak Michael²,Tosato Giovanna¹^ORCID

Affiliation:

1. Laboratory of Cellular Oncology Center for Cancer Research National Cancer InstituteNational Institutes of Health Bethesda MD USA

2. Center for Cancer Research Microscopy Core Laboratory of Cancer Biology and Genetics National Cancer Institute National Institutes of Health Bethesda MD USA

3. Laboratory of Cancer Biology and Genetics Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD USA

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.202114089

Reference55 articles.

1. Tumor Cell–Derived Angiopoietin-2 Promotes Metastasis in Melanoma

2. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis

3. Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins

4. VEGF in Signaling and Disease: Beyond Discovery and Development

5. Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SHP2‐Triggered Endothelial Cell Activation Fuels Estradiol‐Independent Endometrial Sterile Inflammation;Advanced Science;2024-09-05

2. Celebrating the 1945 JNCI pioneering contribution to antiangiogenic therapy for cancer;JNCI: Journal of the National Cancer Institute;2024-08-23

3. Tyrosine phosphatase PTPN11/SHP2 in solid tumors - bull’s eye for targeted therapy?;Frontiers in Immunology;2024-03-05

4. Multiple medicinal chemistry strategies of targeting KRAS: State-of-the art and future directions;Bioorganic Chemistry;2024-03

5. Targets of tumor microenvironment for potential drug development;MedComm – Oncology;2024-03